Answer to Question 1
ANS: D
Nalidixic acid is approved only for urinary tract infections. The drug is not useful against infections outside the urinary tract.
Nalidixic acid will not cover a respiratory tract infection.
Additional doses are not required.
The medication should not be discontinued.
Answer to Question 2
ANS: D
Nitrofurantoin should not be administered to individuals with renal impairment, as indicated by a creatinine clearance of less than 40 mL/min. In the absence of good renal function, levels of nitrofurantoin in the urine are too low to be effective. Also, renal impairment reduces nitrofurantoin excretion, causing plasma levels of the drug to rise, posing a risk of systemic toxicity.
A urine phosphate of 0.9 is within acceptable limits as is a specific gravity of 1.024.
Macrodantin is indicated for cystitis and UTI, thus bacteria in the urine would be expected and not a contraindication.